Increased expression levels of TH1 (IFN-γ), TH2 (IL-31), and TH17/TH22 (IL-23p19/IL-8/S100A12) mRNA expression are molecular features of human AD (Guttman-Yassky et al., 2019). This evidence concerns the gene S100A12 and Alzheimer disease.